Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
Journal of Chemical Information and Modeling|January 24, 2006
A multivariate analysis of HIV-1 protease inhibitors and resistance induced by mutationAnna Maria Almerico, Marco Tutone, Antonino Lauria, et al.Drug Development Research|June 24, 2022
Novel insights on [1,2]oxazolo[5,4-e]isoindoles on multidrug resistant acute myeloid leukemia cell lineManuela Labbozzetta, Marilia Barreca, Virginia Spanò, et al.Bioorganic & Medicinal Chemistry|October 27, 2006
Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activityPatrizia Diana, Annamaria Martorana, Paola Barraja, et al.Journal of Medicinal Chemistry|April 15, 2005
1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agentsAnna Maria Almerico, Francesco Mingoia, Patrizia Diana, et al.Chemmedchem|April 28, 2011
Synthesis and antitumor activity of 3-(2-phenyl-1,3-thiazol-4-yl)-1H-indoles and 3-(2-phenyl-1,3-thiazol-4-yl)-1H-7-azaindolesPatrizia Diana, Anna Carbone, Paola Barraja, et al.Journal of Medicinal Chemistry|June 9, 2017
Pharmaceutical Approaches to Target Antibiotic Resistance MechanismsDomenico Schillaci, Virginia Spanò, Barbara Parrino, et al.Molecules (Basel, Switzerland)|March 3, 2021
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR ProteinVirginia Spanò, Marilia Barreca, Vincenzo Cilibrasi, et al.Bioorganic & Medicinal Chemistry|October 28, 2008
Thiopyrano[2,3-e]indol-2-ones: angelicin heteroanalogues with potent photoantiproliferative activityPaola Barraja, Patrizia Diana, Alessandra Montalbano, et al.ACS Medicinal Chemistry Letters|January 19, 2024
GPCR Inhibition in Treating LymphomaMarilia Barreca, Virginia Spanò, Maria V Raimondi, et al.European Journal of Medicinal Chemistry|September 8, 2020
Current development of CFTR potentiators in the last decadeVirginia Spanò, Arianna Venturini, Michele Genovese, et al.Pageof 8